United Kingdom · What does Caxton Associates invest in?
Caxton Associates invests most often at Series C and Venture (100% of the rounds on record), in sectors such as Biotechnology and Medical Device.
Caxton Associates highlights
- 01
2 rounds on record
- 02
Mostly Series C and Venture: 100% of its rounds
What they do
- Type
- Private equity (from a list, unverified)
- Cheque size
- Not stated
- Stages
- Growth
- Sectors
- BiotechnologyMedical Device
- Based in
- MONACO, United Kingdom
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first2 appearances
- 2010
1 round
- Sept
- 2004
1 round
- Jan
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration5 named
AMAlexander Michael UnderwoodGeneral CounseliForm ADV
AEAndrew Eric LawChairman, Chief Executive Officer and Limited PartneriForm ADV
BSBenjamin Stephan OhlyChief Compliance OfficeriForm ADV
CLChanelle Lorraine NichollsChief Financial OfficeriForm ADV
MDMatthew Duncan WadeChief Operating Officer, Chief Risk Officer and Limited PartneriForm ADV
We also hold 5 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$76Bassets it manages, 2 advisers combinedOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Caxton (monaco) S.a.m.
- SEC number
- CRD 132823
Funds on its Form ADV
6 private funds, $26B in gross assets · filed Mar 2024
- CX Global Advantage LimitedHedge13 investors$6.8B
- CX Macro LimitedHedge146 investors$6.6B
- Caxton International LimitedHedge218 investors$5.2B
- CX Dynamis LimitedHedge57 investors$4.9B
- CX Cadence LimitedHedge4 investors$1.7B
- CX Intaglio LimitedHedge2 investors$465M